Lars Egevad
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research 191
- Prostate Cancer Diagnosis and Treatment 186
- Renal cell carcinoma treatment 26
- Rheumatology top 0.1%
- Urologic and reproductive health conditions 77
- Cancer Research top 0.2%
- Oncology top 0.5%
- Urology top 0.5%
-
- Bladder and Urothelial Cancer Treatments 41
- Genital Health and Disease 32
-
- AI in cancer detection 22
-
- Renal and related cancers 21
- Co-authors
- Brett DelahuntJonathan I. EpsteinJohn R. SrigleyPeter A. HumphreyMahul B. AminRodolfo MontironiPär StattinAnders Bergh
- Journals
- The American Journal of Surgical Pathology (23 papers)Histopathology (22 papers)Pathology (21 papers)
- Partner nations
- SwedenUnited StatesNew Zealand
In The Last Decade
Lars Egevad
326 papers receiving 18.2k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Pulmonary and Respiratory Medicine 12.3k
- Rheumatology 3.2k
- Cancer Research 3.1k
- Oncology 3.3k
- Urology 587
Countries citing papers authored by Lars Egevad
This map shows the geographic impact of Lars Egevad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Egevad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Egevad more than expected).
Fields of papers citing papers by Lars Egevad
This network shows the impact of papers produced by Lars Egevad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Egevad. The network helps show where Lars Egevad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Egevad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 27 | |
| 9 | 2021 | 12 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 24 | |
| 12 | 2019 | 10 | |
| 13 | 2018 | 151 | |
| 14 | 2017 | 17 | |
| 15 | 2017 | 3 | |
| 16 | 2017 | 117 | |
| 17 | 2014 | 107 | |
| 18 | 2014 | 73 | |
| 19 | 2013 | 51 | |
| 20 | 2010 | 49 |
About Lars Egevad
Lars Egevad is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Urology, having authored 336 papers that have together received 18.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (191 papers), Prostate Cancer Diagnosis and Treatment (186 papers), Urologic and reproductive health conditions (77 papers), Bladder and Urothelial Cancer Treatments (41 papers), Genital Health and Disease (32 papers), Renal cell carcinoma treatment (26 papers), AI in cancer detection (22 papers) and Renal and related cancers (21 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (12.3k citations), Rheumatology (3.2k citations) and Cancer Research (3.1k citations). Lars Egevad has collaborated with scholars based in Sweden, United States and New Zealand. Frequent co-authors include Brett Delahunt, Jonathan I. Epstein, John R. Srigley, Peter A. Humphrey, Mahul B. Amin, Rodolfo Montironi, Pär Stattin, Anders Bergh, David J. Grignon and Hemamali Samaratunga. Their work appears in journals such as The American Journal of Surgical Pathology, Histopathology, Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.